comparemela.com

Latest Breaking News On - Maple syrup urine disease - Page 23 : comparemela.com

Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU

Adhoc: Relief Therapeutics Holding SA: Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU

Relief Therapeutics Holding SA / Key word(s): Acquisition Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU 13-Jul-2022

Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form

Relief Therapeutics Holding SA / Key word(s): Patent Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form 08-Jul-2022 / 07:00 CET/CEST Release of an ad hoc anno.

Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form

Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Adm

Relief Therapeutics Holding SA / Key word(s): Patent08-Jul-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Administration.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.